A exploratory controlled clinical study of Apatinib combined TACE in treating advanced hepatocellular carcinoma
Latest Information Update: 20 Oct 2016
At a glance
- Drugs Rivoceranib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 20 Oct 2016 New trial record